Carrington Laboratories announces expanded Central and South American sales distribution agreement.IRVING, Texas--(BUSINESS WIRE)--Dec. 23, 1996--Carrington Laboratories, Inc., (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CARN) has granted exclusive sales distribution rights for wound and skin care products in select Central and South American countries List of American countries Nations:
With the signing of this agreement Carrington products are being sold, registered for sale, or licensed for registration and sale in 19 countries. Under the agreement, Suco receives exclusive sales distribution rights for a period of five years with an option for an additional five years in Colombia, Venezuela, Ecuador, Bolivia, Peru, Paraguay, Uruguay and Haiti. Total population of the area covered under the agreement is more than 120 million people. Suco International is a multi-national pharmaceutical sales distribution organization with principal offices in Dania, Fla. (a Miami suburb suburb, a community in an outlying section of a city or, more commonly, a nearby, politically separate municipality with social and economic ties to the central city. In the 20th cent. ) and sales and distribution facilities strategically located through the region. Suco, which is also the exclusive distributor for Upjohn-Pharmacia products in the area, has more than 400 sales and support staff actively calling on doctors, hospitals, nursing facilities and home health care institutions in the region. Carrington products included under the agreement which will now be sold by these individuals include: Carrasyn(R) Hydrogel hy·dro·gel n. A colloidal gel in which the particles are dispersed in water. hydrogel a gel that contains water. hydrogel Wound care A polymer absorptive wound dressing. See Dressing. Wound Dressing, Carrasyn(R) V (Viscous viscous /vis·cous/ (vis´kus) sticky or gummy; having a high degree of viscosity. vis·cous adj. 1. Having relatively high resistance to flow. 2. Viscid. ) Hydrogel Wound Dressing, Carragauze(R), CarraKlenz(TM) Wound & Skin Cleanser, Carrington(TM) Moisture Barrier Cream and Carrascent(TM). Also included is Carrington's oral care line, starting with The Carrington Patch(TM). "We have worked hard to establish strong, new distribution relationships in the Americas this year. The addition of Suco to our growing list of master distributors assures nearly complete coverage in the Western Hemisphere Western Hemisphere Part of Earth comprising North and South America and the surrounding waters. Longitudes 20° W and 160° E are often considered its boundaries. . In some countries we are selling our products; in others we have registered them for sale or are in the process of registration. This contract paves the way for Carrington to open significant new markets and to begin sales in 1997," said Chris Record, Carrington vice president for business development. Carlton E. Turner, Carrington president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. remarked, "Our goal this year was to make up for lost time in licensing our products beyond the U.S. borders. With the signing of master distributor contracts for Mexico, Canada, Brazil, Italy and the Pacific Rim Pacific Rim, term used to describe the nations bordering the Pacific Ocean and the island countries situated in it. In the post–World War II era, the Pacific Rim has become an increasingly important and interconnected economic region. we have achieved that objective and more. As this year comes to a close, we have licensed our products in 19 countries and are actively seeking more. This accomplishment is a positive view of Carrington products and, more important, what can be accomplished with clear objectives." The statements about this marketing agreement are forward-looking. Actual impact on the company will be dependent upon a number of factors and is subject to a variety of risks including but not limited to the following: subsequent changes in plans by the company's management; delays or problems in product development; changes in industry trends; actions of the company's competitors; regulatory issues; and a number of other factors and risks described from time to time in the company's reports filed with the Securities & Exchange Commission, including the Form 10-Q Form 10-Q See 10-Q. for the quarter ended Sept. 30, 1996. Carrington Laboratories, Inc., is an emerging research-based pharmaceutical and medical device company engaged in developing complex carbohydrate-based therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. and oral technology products, and in manufacturing and marketing products for the management of wounds. Carrington currently has more than 50 products on the market. CONTACT: Carrington Laboratories Inc., Irving Jim Blackmore, 972/714-5046 or 800/471-8817 or Suco International Henry Suarez, 954/927-0066 |
|
||||||||||||||
Bahamas 
Printer friendly
Cite/link
Email
Feedback
Reader Opinion